Cannabidiol 200 Mg/Ml, With The Following Technical Specifications: Cannabis Products (Cdb 11101/Cas 13956-29-1) Containing As Actives Exclusively Vegetable Derivatives Or Phytopharmaceuticals From Cannabis Sativa, Must Contain Cannabidiol (Cbd) And No More Than 0. 2% Tetrahydrocannabinol (Thc). 2. The Pharmaceutical Form Must Be Full Spectrum Oral Solution. 3. The Presentation Of The Medicine Must Consist Of: 3.1 Cartridge, Commercial Packaging In The Format Of A Small Box That Contains The Primary Packaging Of The Medicine, 3.2 The Cartridge Must Contain, In Addition To The Primary Packaging Of The Medicine, An Adapter And Syringe, 3.3 The Primary Packaging Be Made Of Amber Glass, 3.4 Medication, In Oral Solution. The Standard Box, With Capacity For Up To 12 Bottles, Must Have A Maximum Volume Of 0.001 M3, Maximum Gross Weight Of 1.4 Kg, Maximum Net Weight Of 590 G, Maximum Dimensions (Boxxwxx) Of 30X21x25 Cm. 5. The Bidding Company Must Present A Certificate Of Sanitary Authorization For The Cannabis Product, By The Health Surveillance Secretariat. 6. The Bidding Company Must Present, Together With The Required Documentation, Proof Of The Effectiveness Of The Medicine, Through The Presentation Of A Scientific Study That Demonstrates The Benefits Of The Formulation To Be Commercialized. 6.1 In The Case Of A Scientific Study Written In A Foreign Language, It Must Be Translated Into The Official Language Of Brazil By A Sworn Translator, In Accordance With The Following Provisions: I. Art. 18 Of Federal Decree No. 13,609, ..., Trastuzumab 440 Mg (Box With 1 Ampoule Bottle Of Powder For Solution For Intravenous Use + Ampoule Bottle With 20Ml Of Diluent), Lenalidomide 5Mg, Capsules, Lenalidomide 10Mg, Lenalidomide 15Mg, Capsules., Lenalidomide 25Mg, Ibrutinib 140 Mg (With Rev Ct Bl Al Plas Pvc /Pctfe Trans) Comp., Palbociclib 125 Mg, Enzalutamide 40 Mg, Capsule, Osimertinib 80 Mg, Tablets., Olaparib 150 Mg
|